Cas:209163-25-7 2-[3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxopiperidin-1-yl]acetic acid manufacturer & supplier

Chemical Name:2-[3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxopiperidin-1-yl]acetic acid

CAS.NO:209163-25-7

Synonyms:(3-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2-oxo-1-piperidinyl)acetic acid;(3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-oxopiperidin-1-yl)acetic acid;1-Piperidineacetic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-oxo-;Fmoc-(R,S)-3-1-carboxymethyl-2- valerolactame;1-Piperidineaceticacid,3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-oxo;3-(9H-Fluoren-9-ylmethoxycarbonylamino)-2-oxo-piperidin-1-ylacetic acid

Molecular Formula:C₂₂H₂₂N₂O₅

Molecular Weight:394.421

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:686.5±55.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.659

PSA:99.43000

Exact Mass:394.152863

LogP:3.05

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2-oxo-1-piperidinyl)acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(9H-Fluoren-9-ylmethoxycarbonylamino)-2-oxo-piperidin-1-ylacetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-oxopiperidin-1-yl)acetic acid Use and application,(3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-oxopiperidin-1-yl)acetic acid technical grade,usp/ep/jp grade.

Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. 2-[3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxopiperidin-1-yl]acetic acid manufacturer Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. 2-[3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxopiperidin-1-yl]acetic acid supplier Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. 2-[3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxopiperidin-1-yl]acetic acid vendor We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. 2-[3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxopiperidin-1-yl]acetic acid factory Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease.